Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07681713 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

Study acronym: PROVE-FA
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 0 → 9 locationsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to confirm the treatment effects of vatiquinone on the key measures of FA disease progression.
Trial Details
NCT Number NCT07681713
Lead Sponsor PTC Therapeutics
Conditions
(from sponsor)		 Friedreich's Ataxia
Related terms Friedreich Ataxia
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov